BACKGROUND AND PURPOSE: JSRD are rare autosomal recessive brain malformations. We hypothesized that MR imaging can assess fetuses at risk for JSRD and might influence their diagnoses.
MR imaging plays the cornerstone in establishing the diagnosis of JSRD. MTS is the cardinal diagnostic sign visualized on axial imaging at the pontomesencephalic junction in almost all cases of JSRD. [5] [6] [7] [8] [9] MTS describes narrow isthmus, deep interpeduncular fossa, and thick horizontally placed superior cerebellar peduncles. [5] [6] [7] Other MR imaging signs include a midline cerebellar cleft in place of the hypoplastic vermis on coronal images, as well as the characteristic anteriorly convex floor of the fourth ventricle on axial images. 6, 8, 9 The prognosis of JSRD could be poor, as it is associated with severe mental and motor retardation in many cases. 10, 11 Parents of a child with JSRD have a 25% chance of conceiving an affected fetus with each pregnancy. 4, 12, 13 For a woman pregnant with a fetus at risk for a devastating anomaly such as JSRD, prenatal diagnosis may facilitate informed reproductive choices, reduce anxiety through reassurance, or enable preparations for the birth of an affected child. 14 The genetic basis of JSRD includes a diverse set of 3 causative genes and 2 other unique loci where the genes have not yet been identified. Mutations of one of the causative genes of Meckel-Gruber syndrome, MKS3, have also been found recently in patients with classical JS and CORS. 13 This genetic heterogeneity makes a molecular prenatal diagnosis in JSRD a challenge. 15 Amniocentesis and chorionic villus sampling are not helpful in JSRD because DNA and protein markers for most types are not widely available on a clinical basis. 13 Prenatal US diagnosis of JSRD has proved difficult because of the known limitations in US imaging of the fetal posterior fossa, the rarity of the condition, and the relatively nonspecific findings reported in most affected fetuses. [16] [17] [18] [19] [20] Fetal MR imaging is now acknowledged as the method of choice to delineate posterior fossa malformations in a fetus. [21] [22] [23] However, MR imaging findings in fetuses at risk for JSRD were only reported in the literature in 2 case reports. 24, 25 The positive and negative predictive values of MR imaging findings for diagnosing JSRD in utero are not yet known. 17, 19, 24 We hypothesized in this study that MR imaging can assess fetuses at risk for JSRD and might influence their diagnoses.
Materials and Methods

Patients
The patients were enrolled in a sequential fashion in the Genetics Clinic at National Research Centre, Cairo, Egypt, between June 2004 and May 2008, from families meeting inclusion criteria for JSRD in this institutional review board-approved study. The inclusion criteria included a family member or more with the typical MTS brain imaging finding in addition to clinical evidence of the syndrome (hypotonia and developmental delay, accompanied by either abnormal breathing or abnormal eye movement). No exclusion criteria were specified. Twelve fetuses with a mean GA of 23 weeks (SD 3.7; range, 18 -30; median, 22) from 12 Egyptian families were studied. The mean age of the mothers was 30.2 years (SD 5.7). Eight families were first-cousin marriages, 2 had more distant documented consanguinity, and negative consanguinity was reported in 2 families. Seven of the families had more than a single affected member. In no instance was there a symptomatic parent. JSRD phenotypes were ascertained in all of the affected family members. The classical form of the JS was documented in 11 families with its characteristic clinical features of hypotonia, psychomotor delay, oculomotor apraxia, neonatal breathing dysregulation, pigmentary retinal changes, and polydactyly; COACH was diagnosed in 1 family with cerebellar vermis hypoplasia, oligophrenia, ataxia, coloboma, and hepatic fibrosis. The on-line Table shows the clinical and imaging data of the classical JS-affected family members. Brain MR imaging studies of all of the classic JSaffected family members showed the characteristic MTS. Brain abnormalities other than MTS were brain stem hypoplasia in JSRDaffected family members of case 4, as well as unilateral polymicrogyria and thin corpus callosum in JSRD-affected family members of case 8.
All of the cases were referred with detailed fetal 2D and 3D neurosonographic studies that were performed 0 to 5 days (average, 3; SD 1.5) before MR imaging by physicians experienced in fetal US imaging by using 2.5-5.0 MHz transducers of Accuvix XQ (Medison, Seoul, Korea) or Voluson E8 (GE Healthcare, Milwaukee, Wisconsin) sonography scanners. Vaginal US scans with 4 -8-or 6 -12-MHz transducers were attempted when the fetus was in cephalic position. US studies were done with knowledge of the patient's history. The on-line Table includes the referred prenatal US findings of the 12 fetuses at high risk for JSRD: 7 fetuses were diagnosed as normal; 3 fetuses had equivocal US findings where no brain abnormalities were detected or could be ruled out due to inability to obtain a midsagittal image or reverberating artifacts of the posterior fossa; 1 fetus had a suspicious prominent CM (9 mm); and 1 fetus had equivocal neurosonographic findings of the posterior fossa but JSRD was suspected upon detection of polydactyly.
Fetal MR Imaging Technique
Written consents were obtained from the mothers of the studied fetuses and control group. Fetal MR imaging was performed with a 1.5T superconducting magnet (Intera; Philips Medical Systems, Best, the Netherlands) and a phased-array surface coil. No patients were excluded because of contraindication to MR imaging or claustrophobia.
Brain images were obtained in multiple planes by using T2-weighted balanced fast-field echo (Philips proprietary version of steady-state free precession) with TR/TE of 3.5-4 ms/1.7-2 ms, FA of 60 -90, 2 signals acquired, 256 ϫ 256 matrix, and 4-mm section thickness without intersection gap. No contrast agents or sedatives were used. All fetal MR imaging studies were interpreted by the radiologist in this study with more than 18 years of experience in neuroimaging and more than 8 years of experience in fetal MR imaging. The MR images of the 12 fetuses at risk for JSRD were assessed for posterior fossa abnormalities commonly reported in JSRD: MTS, dysplastic vermis, midline cerebellar cleft in place of the hypoplastic vermis on coronal images, and the characteristic anteriorly convex floor of the fourth ventricle on axial images. Fetal MR images were also assessed for any associated brain abnormalities. For definitive diagnosis, we correlated fetal MR imaging findings with detailed postnatal clinical examination.
Outcome Measures
The expectant parents and their referring physicians were informed of the results of the fetal MR imaging with the caveat that the study is investigative and of unproven accuracy for diagnosing JSRD. All live births underwent postnatal assessment within the first month of life that was repeated at 12-24 months of age supervised by the pediatrician-geneticist in this study with 20 years of experience. Postnatal examination included detailed physical and neurologic assessment with particular attention to findings commonly seen in JSRD, such as characteristic tachypnea-apnea spells, abnormal eye movements (skew deviations and nystagmus), and abnormal muscle tone (hypotonia). Postnatal assessment included a standard developmental profile to detect for any psychomotor delay; blood chemistry tests for elevations in blood urea nitrogen, creatinine, and liver transaminases to evaluate for evidence of impaired organ function; abdominal US to detect for any renal or hepatic abnormalities; and a baseline eye examination to test for retinal dysplasia and coloboma. When visual problems were suspected, VEP study and ERG were done. Infants who showed abnormal physical signs or delayed development had a detailed brain MR imaging.
According to the final diagnosis, the 12 studied cases were grouped as either JSRD-affected or JSRD-nonaffected.
Retrospectively, we obtained multiple posterior fossa measurements in the prenatal MR imaging of both groups (JSRD-affected and JSRD-nonaffected). The initial fetal MR imaging and the subsequent measurements of the posterior fossa were assessed by the neuroradiologist in this study. On a midsagittal imaging, we measured the maximum AP diameter of the CM as well as the maximum superiorinferior diameter of the vermis. On axial images showing the cerebellum, we measured the maximum transverse cerebellar diameters. On axial images at the level of lower midbrain-pontomesencephalic junction, where abnormalities are commonly seen in JSRD, we measured the AP diameter of IP fossa, AP diameter of the midbrain/isthmus, as well as the AP and transverse diameters of the fourth ventricle. We calculated the ratio between measurements at the pontomesencephalic junction (AP of IP fossa to AP of isthmus as well as AP to transverse diameters of the fourth ventricle) to quantify morphologic changes of the structures at this level. We correlated the measurements with those of normal fetuses at the same GA available in fetal biometry. [26] [27] [28] We compared MR imaging measurements obtained in fetuses at risk for JSRD with those of 24 age-matched fetuses (average, 22.2 weeks; SD 3.3; range, 18 -30; median, 21.5) with normal in utero brain MR imaging studies that were confirmed by normal detailed postnatal clinical and neurologic examination at an average age of 15.5 months (SD 5.3) and normal postnatal MR imaging done at an average age of 4.1 months (SD 2.3). Cases for the control group were selected from a large pool of participants in our study of MR imaging for at-risk pregnancies for brain anomalies.
Statistical Methods
We compared the MR imaging measurements obtained in the 3 groups by using independent 2-tailed t test. To control variation of GA in the studied cases, ANCOVA was used where the GA was the covariate, all of the MR imaging findings were the dependent test, and the affected group was the independent variable. A P value of Ͻ0.05 level was considered significant. Post hoc statistical power analysis was calculated. The statistical analysis was done by using SPSS, version 12 (SPSS, Chicago, Illinois).
Results
Prospectively, MR imaging diagnosed 9 fetuses as normal (Fig  1) . The 9 cases showed normal physical and neurologic examinations during the first month of life as well as on follow-up clinical examinations until an average age of 16 months (SD 6).
In the other 3 fetuses, MR imaging showed suspected diagnosis of JSRD at 22 weeks (Fig 2) , 30 weeks (Fig 3) , and 28 weeks of gestation upon detection of MTS, a midline cerebellar cleft in place of the hypoplastic vermis on coronal images, and deformed anteriorly convex floor of the fourth ventricle on axial images. The MTS was mild in the 3 fetuses with a less notable affection of the superior cerebellar peduncles in the fetus diagnosed at 22 weeks (Fig 2A) . AP diameter of the CM measured 11, 8, and 9 mm in fetuses diagnosed as JSRD-affected at 22 (case 2), 30 (case 6), and 28 weeks (case 9) of gestation, respectively. Superior-inferior diameters of cerebellar vermis were not reliably measured in JSRD-affected cases due to pseudovermis appearance of the cerebellar hemispheres at the midsagittal images (Fig 2A) . There were no abnormal MR imaging findings related to the developing cerebral cortex, sulci, or supratentorial ventricles in any of the studied fetuses.
Postnatal examination of the 3 cases diagnosed as JSRDaffected with MR imaging showed 1 female and 2 males (cases 2, 6, and 9) with physical and neurologic examinations impressive of JSRD (on-line Table) . Postnatal MR imaging of the 3 cases showed MTS without any associated abnormalities related to the cerebral cortex, sulci, corpus callosum, olfactory bulbs, optic tracts, or supratentorial ventricles. Retrospective analysis of fetal MR imaging posterior fossa measurements in cases that were proved to be normal were statistically close to control group by using 2-tailed t test; the measurements matched also those of normal fetuses at corresponding GAs in fetal biometry. [26] [27] [28] By comparing the mean and ratios of posterior fossa measurements in the different groups, those of the JSRD-affected group were higher than those in JSRD-nonaffected fetuses and the control group. The mean AP diameter of the cisterna magna measured 9.3 mm (SD 1.5) compared with 7 mm (SD 2.2) in nonaffected cases and 6 mm (SD 1.1) in the control group. At the pontomesencephalic junction (Fig 3C) , the mean ratio of AP diameter of the IP fossa to that of the midbrain/isthmus was significantly higher in JSRDaffected cases (0.9; SD 0.1) than in nonaffected cases (0.41; SD 0.04) and the control group (0.34; SD 0.08). The mean ratio of the AP to transverse diameters of the fourth ventricle was higher in JSRD-affected cases (1.65; SD 0.35) than in nonaffected cases (0.9; SD 0.2) and in the control group (0.9; SD 0.3).
Comparison between the JSRD-affected and control groups as well between JSRD-affected and nonaffected groups in the following MR imaging findings by using independent 2-tailed Student t test revealed: ratio of AP-to-transverse diameters of fourth ventricle (P Ͻ .0001 and .0001), AP diameter of CM (P Ͻ .0001 and .05), transverse cerebellar diameter (P Ͻ .004 and .003), superior-inferior diameter of vermis (P Ͻ .029 and .009), and IP-to-isthmus ratio (P Ͻ .0001 and .0001). Power analysis ranged from 65% to 75% for the JSRD-affected compared with nonaffected groups and from 70% to 80% for the JSRD-affected group compared with the normal controls. The effect size estimation ranged from 0.57 to 1.6 for the JSRD-affected group compared with the nonaffected groups and from 0.8 to 1.9 for JSRD-affected compared with control groups in the above-mentioned parameters.
An ANCOVA test suggested a strong relationship between the studied MR imaging findings and the JSRD-affected group controlling for GA at a P value of Ͻ.05 for the following MR imaging findings: AP diameter of the CM (P Ͻ .008), superoinferior diameter of vermis (P Ͻ .0001), IP fossa-to-isthmus ratio (P Ͻ .0001), ratio of AP-to-transverse diameters of the fourth ventricle (P Ͻ .0001), and maximum transverse cerebellar diameter (P Ͻ .0001). The ANCOVA test eliminated the potential effect of GA variation on the JSRD-affected group results.
Discussion
We report in this study 12 families with a history of siblings who were diagnosed with JSRD. Parents of a child with JSRD have a 25% chance of conceiving an affected fetus with each pregnancy. 3 Because inbreeding has been demonstrated to approximately double the rate of a recessive disease in a given population, JSRD are more commonly manifested in Egypt known with its high rate (30%-40%) of marriages in consanguineous couples. 12, 13 Ten out of 12 families (83.3%) in our study had positive consanguinity, and 7 families (58.3%) had more than 1 affected sibling mostly with severe mental and motor retardation.
Difficulties in prenatal imaging of JSRD are attributed to the rarity of the condition (1/100,000 live births). [16] [17] [18] [19] [20] To the best of our knowledge, prenatal imaging of JSRD was described in the literature in only 14 fetuses, most of which were examined by US. 16, 18, 19, 24, 25, [29] [30] [31] [32] [33] [34] [35] All fetuses at risk of JSRD in this study were referred with either normal or equivocal neurosonographic findings. Limitations of US imaging of fetal posterior fossa are widely reported. [36] [37] [38] Other studies documented significant discrepancies in sonographic prenatal diagnosis and postnatal diagnosis of posterior fossa malformations, especially vermian abnormalities. [38] [39] [40] Moreover, prenatal US findings in JSRD are relatively nonspecific and include dilated CM, vermian hypoplasia, occipital encephalocele, and ventriculomegaly. [16] [17] [18] [19] [20] 24 US diagnosis of JSRD in utero usually relies on a positive family history and the finding of abnormal posterior fossa anatomy or the presence of asso- ciated suggestive features such as kidney anomalies or polydactyly. 19, 25 In this study, US suspected JSRD in a fetus upon detecting polydactyly rather than revealing brain abnormalities.
Fetal MR imaging does not suffer from the US imaging restraints and is now acknowledged as the method of choice in imaging the posterior fossa in utero. 23 In a recent study, Tilea and colleagues 41 found that both fetal MR imaging and fetopathology had similar performance with respect to the detection of vermian agenesis and brain stem abnormalities. The researchers concluded that a systematic analysis of the posterior fossa in fetal MR imaging makes it possible to diagnose accurately most noncystic posterior fossa malformations. 41 Although fetal MR imaging is useful in diagnosing posterior fossa anomalies, its sensitivity in JS has not been systematically evaluated. To the best of our knowledge, a total of 3 fetuses at risk of JSRD were examined by MR imaging in 2 reports; 2 out of the 3 fetuses proved to be JSRD-affected, while the third case was normal. 24, 25 In a report by Doherty and colleagues, fetal MR imaging suggested affection in a fetus at 21 weeks of gestation by showing vermian hypoplasia without being able to demonstrate a MTS. 24 Aslan and colleagues, too, diagnosed JSRD in utero by demonstrating vermis hypoplasia. 19 Vermis hypoplasia appears as a fluid communication between the fourth ventricle and the CM that persists after 18 weeks of gestation. 9 In the JSRD-affected fetuses in this study, a midline cerebellar cleft in place of the hypoplastic vermis on coronal images pointed to vermian hypoplasia ( Fig  2D) . Precise measurement of the midline cerebellum was not possible in the JSRD-affected fetuses due to herniation of cerebellar hemispheres at the midsagittal MR images, which gave a pseudovermis appearance and erroneous impression of intact midline cerebellum ( Figs 2C and 3A) . In the 3 JSRD-affected fetuses in this study, the CM was either mildly dilated or at the high limit of normal measurements (9.5 mm); this is in concordance with Doherty and colleagues' report 24 ( Figs 2C  and 3A) . However, neither CM dilation nor vermian hypoplasia is pathognomonic of JSRD being shared with other posterior fossa malformations such as DWM, isolated vermian hypoplasia, pontocerebellar hypoplasia, and craniocerebellocardiac syndrome. [16] [17] [18] [19] [20] MTS is considered the cardinal diagnostic imaging sign for JSRD. [5] [6] [7] 9, 13 In 1 study, the MTS was reported to be pathognomonic of this anomaly. 5 The underlying pathology of MTS is lack of normal decussation of superior cerebellar peduncular fibers that leads to enlarged peduncles that follow a more horizontal course between the midbrain and the cerebellum. 2 The absence of crossing fibers is responsible for the decreased anteroposterior diameter of the midbrain and causes the interpeduncular cistern to be deeper than that in the normal brain. The clinical manifestations in JSRD may be caused by the inability of the posterior fossa fiber tracts to cross the midline. 5 The identification of MTS by fetal MR imaging has been documented in literature in a single report at 27 weeks of gestation. 25 Fetal MR imaging identified MTS in all of the 3 JSRDaffected fetuses in our study as early as 22 weeks of gestation (Figs 2A and 3B) . The thick horizontally oriented superior cerebellar peduncles, however, were more prominent in the 2 cases diagnosed later in gestation at 28 and 30 weeks (Fig 3B) . Fetal MR imaging identified the fourth ventricular deformity in the JSRD-affected fetuses in this study. On sagittal MR images (Fig 2C) , the fourth ventricle of the JSRD-affected fetuses was abnormally rounded and lacked the characteristic posterior point (fastigial point). Axial MR images (Fig 2A) showed the deformed anteriorly convex floor of the fourth ventricle, the appearance of which resulted from lack of decussation of the superior cerebellar peduncles in the tegmentum. 25 For a couple who has already had a child with JSRD, presence of posterior fossa abnormality is significant; however, the absence of evident signs does not preclude a diagnosis because of the unknown sensitivity and because of possible intrafamilial variability. 24, 25 Aiming at identification of possible objective key features for in utero diagnosis of JSRD, we retrospectively compared posterior fossa measurements and ratios in prenatal MR imaging of the JSRD-affected and JSRD-nonaffected fetuses with those of a normal control group. Fetuses diagnosed by MR imaging as being JSRD-nonaffected by pre- Note that the AP diameter of the interpeduncular fossa is almost equal to that of the narrow isthmus and the AP diameter of the superior aspect of the fourth ventricle is longer than its transverse diameter natal MR imaging were close to the control group in all of the obtained measurements. However, there was variation in measurements between the JSRD-affected group and normal fetuses at the pontomensencephalic junction. Unlike normal fetuses, the abnormally deep IP fossa in JSRD-affected fetuses was almost equal in its AP dimension to that of the dysgenetic isthmus (Figs 2A and 3A) . Additionally, the average ratio of AP-to-transverse dimensions of the deformed fourth ventricle at the level of the dysgenetic isthmus in JSRD-affected fetuses was almost doubled (Fig 3B) in comparison to JSRD-nonaffected fetuses and control subjects. Ratios of measurements at the pontomesencephalic junction could be a potential objective key to enhance in utero diagnosis of JSRD, especially in cases with subtle MTS (Fig 2A) .
A limitation of this study is that the imaging findings were determined by a single neuroradiologist, and thus the interrater reliability is unknown. Another limitation is the relatively small sample size that may influence the statistical reliability of the study, and other variables may be significant with a larger sample. The statistical power of this study ranges between 65% and 80%; by convention, 80% is the acceptable level of power. However, this study opens the door for further prospective and retrospective works to evaluate the diagnostic ability and accuracy of MR imaging findings and measurements in fetuses at risk of JSRD.
Counseling and management decisions for parents of a fetus diagnosed with fetal anomalies are multifactorial. The decision to terminate or to continue the pregnancy depends on the GA at diagnosis, the severity and type of the abnormality, presence of multiple anomalies, as well as social and religious views.
14 Fetal MR imaging increased the confidence in continuation of pregnancies with normal MR findings, and in this study all of them showed normal postnatal outcome. Abnormal fetal MR imaging findings enabled preparations for the birth of JSRD-affected children with respiratory abnormalities in a tertiary care hospital with a specialized neonatal care unit.
Conclusions
Fetal MR imaging can diagnose JSRD in at-risk pregnancies by detecting characteristic posterior fossa signs such as MTS. Measurements at the pontomesencephalic junction may enhance the accuracy of fetal MR imaging diagnosis of JSRD, especially in cases with subtle or equivocal findings.
